Atlanticus Holdings (NASDAQ:ATLC) reported quarterly earnings of $0.98 per share which missed the analyst consensus estimate of $1.50 by 34.67 percent. This is a 53.99 percent decrease over earnings of $2.13 per share from the same period last year. The company reported quarterly sales of $269.09 million which missed the analyst consensus estimate of $290.54 million by 7.38 percent. This is a 23.85 percent increase over sales of $217.27 million the same period last year.
EF Hutton Initiates Coverage On GT Biopharma with Hold Rating, Announces Price Target of $2
EF Hutton analyst Tony Butler initiates coverage on GT Biopharma (NASDAQ:GTBP) with a Hold rating and announces Price Target of $2.
